Byproducts in the synthesis of [⁶⁸Ga]Ga-PSMA-11

Affiliations

¹ Institute of Pharmacy, University of Hamburg, Hamburg, Germany. ata.makarem@uni-hamburg.de.
² College of Chemical Engineering, Nanjing Forestry University, Nanjing, China.
³ Molecular Structure Analysis, German Cancer Research Center, Heidelberg, Germany.

Ata Makarem et al. Nat Protoc. 2025.

. 2025 Apr 18.

doi: 10.1038/s41596-025-01164-6. Online ahead of print.

¹ Institute of Pharmacy, University of Hamburg, Hamburg, Germany. ata.makarem@uni-hamburg.de.
² College of Chemical Engineering, Nanjing Forestry University, Nanjing, China.
³ Molecular Structure Analysis, German Cancer Research Center, Heidelberg, Germany.

No abstract available

Conflict of interest statement

Competing interests: The authors declare no competing interests.

1. Eder, M. et al. Novel preclinical and radiopharmaceutical aspects of [⁶⁸Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer. Pharmaceuticals 7, 779–796 (2014).
1. Eder, M. et al. ⁶⁸Ga-Complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging. Bioconjug. Chem. 23, 688–697 (2012). - DOI - PubMed
1. Rodnick, M. E. et al. Synthesis of ⁶⁸Ga-radiopharmaceuticals using both generator-derived and cyclotron-produced ⁶⁸Ga as exemplified by [⁶⁸Ga]Ga-PSMA-11 for prostate cancer PET imaging. Nat. Protoc. 17, 980–1003 (2022). - DOI - PubMed
1. Martin, S. et al. Identification, characterization, and suppression of side products formed during the synthesis of [¹⁷⁷Lu]Lu-PSMA-617. J. Med. Chem. 64, 4960–4971 (2021). - DOI - PubMed
1. Ioppolo, J. A., Alvarez de Eulate, E., Cullen, D. R., Mohamed, S. & Morandeau, L. Development of a high‐performance liquid chromatography method for rapid radiochemical purity measurement of [¹⁸F]PSMA‐1007, a PET radiopharmaceutical for detection of prostate cancer. J. Label. Compd. Radiopharm. 66, 58–72 (2023). - DOI